Cargando…
Unmet needs in squamous cell carcinoma of the lung: potential role for immunotherapy
Squamous cell carcinoma of the lung accounts for 20–30 % of non-small cell lung cancers (NSCLC). Despite the differences in disease characteristics between squamous and non-squamous NSCLC, both have historically been treated similarly in the clinic. Recently approved drugs have revealed differences...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4006124/ https://www.ncbi.nlm.nih.gov/pubmed/24748366 http://dx.doi.org/10.1007/s12032-014-0960-1 |